Insider Notice: GSAT 52,667-Share Sale via UBS on Nasdaq

Rhea-AI Filing Summary

Form 144 notice to sell restricted/common stock via broker on Nasdaq. The filing shows an intended sale of 52,667 shares of common stock through UBS Financial Services in New York with an aggregate market value of $1,702,439.71. The filing reports 126,672,742 shares outstanding and lists an approximate sale date of 09/10/2025. The shares were acquired on 10/06/2017 from the issuer. The filer reports no securities sold in the past three months and makes the customary representation that they do not possess undisclosed material adverse information. Other issuer identifying fields in the form are blank.

Insights

Securities Analyst

TL;DR: A small planned insider sale: 52,667 shares (~0.042% of outstanding) valued at ~$1.7M on Nasdaq via UBS.

The filing documents a proposed sale of restricted/common shares through UBS with an approximate sale date of 09/10/2025. The position being sold represents roughly 0.042% of the reported 126,672,742 shares outstanding, indicating this is a relatively small disposition in relation to the company's float. The shares were originally acquired from the issuer on 10/06/2017. No sales in the prior three months are reported. This type of Form 144 is routine and typically reflects liquidity needs of an insider or resale of restricted stock; it does not, by itself, indicate a change in company fundamentals.

Corporate Governance Expert

TL;DR: Procedural disclosure of an insider sale; reporting appears standard but issuer identity fields are not populated in the content.

The submission contains required broker information (UBS Financial Services) and sale specifics but omits explicit issuer-identifying entries within the provided form content. The filer affirms absence of undisclosed material adverse information and notes no recent sales in the three-month lookback. From a governance perspective, the notice meets the basic Rule 144 disclosure elements provided here; however, the missing issuer-identification fields in the extracted content reduce transparency in this snippet.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	52667	1702439.71	126672742	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/06/2017	Various	Issuer			52667	10/06/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for GSAT report?

The form reports a proposed sale of 52,667 common shares via UBS with an aggregate market value of $1,702,439.71 and an approximate sale date of 09/10/2025.

How many shares outstanding are reported in the filing?

The filing lists 126,672,742 shares outstanding.

When were the shares to be sold originally acquired?

The shares were acquired on 10/06/2017 from the issuer.

Were any securities sold by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale?

The broker is listed as UBS Financial Services, Inc., 11 Madison Avenue, 4th Floor, New York, NY 10010 and the sale is to occur on NASDAQ.